Search results
Mounjaro vs. Ozempic: Which Is Better for Weight Loss?
MediaFeed via AOL· 3 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
Most slow responders to tirzepatide do lose clinically meaningful weight
Medical Xpress· 11 hours agoAmong slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically...
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
Benzinga via Yahoo Finance· 10 hours agoEli Lilly And Co (NYSE:LLY) has reportedly reached a settlement agreement with a medi spa that sold...
The pros and cons of weight-loss drugs
The Telegraph via Yahoo News· 2 days agoThe new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that regulates insulin levels and...
If at First Tirzepatide Doesn't Succeed, Keep Trying
Medscape· 6 days agoWhen using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off. New post hoc data from Lilly's SURMOUNT-1 trial of people with...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 11 hours agoBut sales of diabetes drugs Mounjaro and Trulicity missed forecasts. Lilly says it's boosting...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks via Yahoo Finance· 12 hours agoEli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and...
CNN via Yahoo News· 2 days agoNew analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on...
Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually
MedPage Today· 6 days agoThe vast majority of patients with obesity who responded slowly to the once-weekly injectable ...
Celebrities can't lose weight without people speculating they're on Ozempic. Here's who's addressed...
INSIDER via Yahoo News· 2 days agoSemaglutide was FDA-approved to treat obesity in 2021. Tirzepatide, marketed as Mounjaro for...